Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026)

Treace Medical Concepts (TMCI) has 6 years of Return on Capital Employed data on file, last reported at 36.47% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 713.0% year-over-year to 36.47%; the trailing twelve-month figure through Mar 2026 stood at 36.47% (down 713.0% YoY), and the FY2025 full-year result was 31.27%, down 336.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 36.47%, down from 33.23% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 18.09% in Q1 2022 and bottomed at 36.47% in Q1 2026.
• The 5-year median for Return on Capital Employed is 28.27% (2024), against an average of 27.73%.
• The widest annual swing landed in 2022, when Return on Capital Employed slumped 2173 bps; it then soared 503 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 27.33% in 2022, then climbed by 6 bps to 25.57% in 2023, then slipped by 21 bps to 30.92% in 2024, then fell by 7 bps to 33.23% in 2025, then retreated by 10 bps to 36.47% in 2026.
• The last three Return on Capital Employed figures came in at 36.47% (Q1 2026), 33.23% (Q4 2025), and 30.16% (Q3 2025), per Business Quant data.

Peer Comparison